141 related articles for article (PubMed ID: 34275207)
21. Childhood diabetes mellitus and early-onset kidney diseases later in life: a nationwide population-based matched cohort study.
Sun J; Wang C; Zhao M; Lee PMY; Xi B; Yu Y; Li J
BMC Med; 2022 Nov; 20(1):428. PubMed ID: 36348418
[TBL] [Abstract][Full Text] [Related]
22. DKA cases over the last three years: has anything changed?
Stratigou T; Vallianou N; Vlassopoulou B; Tzanela M; Vassiliadi D; Ioannidis G; Tsagarakis S
Diabetes Metab Syndr; 2019; 13(2):1639-1641. PubMed ID: 31336534
[TBL] [Abstract][Full Text] [Related]
23. Urinary C-peptide creatinine ratio to differentiate type 2 diabetes mellitus from type 1 in pediatric patients.
Elzahar W; Arafa A; Youssef A; Erfan A; El Amrousy D
Eur J Pediatr; 2020 Jul; 179(7):1115-1120. PubMed ID: 32052124
[TBL] [Abstract][Full Text] [Related]
24. Vomiting and hyperkalemia are novel clues for emergency room diagnosis of type 1 diabetic ketoacidosis: a retrospective comparison between diabetes types.
Takai T; Okada Y; Takebe R; Nakamura T
Diabetol Int; 2022 Jan; 13(1):272-279. PubMed ID: 35059263
[TBL] [Abstract][Full Text] [Related]
25. Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy.
Le Moli R; Muscia V; Tumminia A; Frittitta L; Buscema M; Palermo F; Sciacca L; Squatrito S; Vigneri R
Nutr Metab Cardiovasc Dis; 2015 May; 25(5):452-7. PubMed ID: 25746910
[TBL] [Abstract][Full Text] [Related]
26. [The prevalence of hypertension and microalbuminuria in diabetes mellitus type 1 and type 2].
Vasović O; Zamaklar M; Lalić K; Milosević D; Zikić L; Popović L
Srp Arh Celok Lek; 2005; 133(5-6):229-32. PubMed ID: 16392277
[TBL] [Abstract][Full Text] [Related]
27. Immune Checkpoint Inhibitor-Induced Diabetic Ketoacidosis: A Report of Four Cases and Literature Review.
Hong AR; Yoon JH; Kim HK; Kang HC
Front Endocrinol (Lausanne); 2020; 11():14. PubMed ID: 32047478
[TBL] [Abstract][Full Text] [Related]
28. FAMILY HISTORY OF DIABETES IS ASSOCIATED WITH INCREASED RISK OF RECURRENT DIABETIC KETOACIDOSIS IN PEDIATRIC PATIENTS.
Vakharia JD; Agrawal S; Molino J; Topor LS
Endocr Pract; 2020 Mar; 26(3):305-311. PubMed ID: 31859553
[No Abstract] [Full Text] [Related]
29. Identifying type 1 and type 2 diabetic cases using administrative data: a tree-structured model.
Lo-Ciganic W; Zgibor JC; Ruppert K; Arena VC; Stone RA
J Diabetes Sci Technol; 2011 May; 5(3):486-93. PubMed ID: 21722564
[TBL] [Abstract][Full Text] [Related]
30. Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes.
Koch KL; Hasler WL; Yates KP; Parkman HP; Pasricha PJ; Calles-Escandon J; Snape WJ; Abell TL; McCallum RW; Nguyen LA; Sarosiek I; Farrugia G; Tonascia J; Lee L; Miriel L; Hamilton F;
Neurogastroenterol Motil; 2016 Jul; 28(7):1001-15. PubMed ID: 26946489
[TBL] [Abstract][Full Text] [Related]
31. Long-term safety and effectiveness of biosimilar insulin glargine in Japanese patients with diabetes mellitus in routine clinical practice: results of a post-marketing safety study.
Shingaki T; Taki K; Koyanagi M; Nagaoka S; Yoshizawa K; Oki N; Yoshikawa A; Imaoka T
Curr Med Res Opin; 2020 Jun; 36(6):947-958. PubMed ID: 32271092
[No Abstract] [Full Text] [Related]
32. Characteristics of diabetic ketoacidosis in Chinese adults and adolescents -- a teaching hospital-based analysis.
Tan H; Zhou Y; Yu Y
Diabetes Res Clin Pract; 2012 Aug; 97(2):306-12. PubMed ID: 22704172
[TBL] [Abstract][Full Text] [Related]
33. The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors.
Marchand L; Disse E; Dalle S; Reffet S; Vouillarmet J; Fabien N; Thivolet C; Cugnet-Anceau C
Acta Diabetol; 2019 Dec; 56(12):1239-1245. PubMed ID: 31423559
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of diabetes mellitus in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-DM study.
Ruiz-García A; Arranz-Martínez E; García-Álvarez JC; García-Fernández ME; Palacios-Martínez D; Montero-Costa A; Ciria-de-Pablo C; López-Uriarte B; García-Pliego RA; Chao-Escuer P; Zafra-Urango C; Alcaraz-Bethencourt A; Redondo-de-Pedro S; Escamilla-Guijarro N; Pascual-Val T; Vieira-Pascual MC; Martínez-Irazusta J; Martínez-Cid-de-Rivera E; Rodríguez-de-Cossío Á; de-Prado-Prieto L; Adrián-Sanz M; Minguela-Puras ME; Blanco-Canseco JM; Rubio-Villar M; Berbil-Bautista ML; Hueso-Quesada R; Plata-Barajas MT; Redondo-Sánchez M; Durán-Tejada MR; García-Redondo MR; Sánchez-Herráiz M; Rey-López AM; García-García-Alcañiz MP; Abad-Schilling C; Hidalgo-Calleja Y; Rivera-Teijido M;
Clin Investig Arterioscler; 2020; 32(1):15-26. PubMed ID: 31130360
[TBL] [Abstract][Full Text] [Related]
35. Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.
Espi M; Teuma C; Novel-Catin E; Maillet D; Souquet PJ; Dalle S; Koppe L; Fouque D
Eur J Cancer; 2021 Apr; 147():29-39. PubMed ID: 33607383
[TBL] [Abstract][Full Text] [Related]
36. Gustatory sweating in people with type 1 and type 2 diabetes mellitus: Prevalence and risk factors.
Klarskov CK; von Rohden E; Thorsteinsson B; Tarnow L; Lommer Kristensen P
Endocrinol Diabetes Metab; 2021 Oct; 4(4):e00290. PubMed ID: 34505414
[TBL] [Abstract][Full Text] [Related]
37. Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.
Wang L; Voss EA; Weaver J; Hester L; Yuan Z; DeFalco F; Schuemie MJ; Ryan PB; Sun D; Freedman A; Alba M; Lind J; Meininger G; Berlin JA; Rosenthal N
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1620-1628. PubMed ID: 31456304
[TBL] [Abstract][Full Text] [Related]
38. Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort Study.
Zhong VW; Juhaeri J; Mayer-Davis EJ
Diabetes Care; 2018 Sep; 41(9):1870-1877. PubMed ID: 29386248
[TBL] [Abstract][Full Text] [Related]
39. Distinct changes to pancreatic volume rather than pancreatic autoantibody positivity: insights into immune checkpoint inhibitors induced diabetes mellitus.
Wei HH; Lai YC; Lin G; Lin CW; Chang YC; Chang JW; Liou MJ; Chen IW
Diabetol Metab Syndr; 2024 Jan; 16(1):26. PubMed ID: 38254155
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
